New York, March 27 – JPMorgan Chase Financial Co. LLC priced $1.65 million of 0% autocallable buffered return enhanced notes due March 26, 2026 linked to the iShares U.S. Medical Devices ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be called automatically at a premium of 10.62% if the ETF closes at or above its initial value on March 31, 2025.
If the ETF gains, the payout at maturity will be par plus 125% of the ETF return.
Investors will receive par if the ETF declines by no more than 10% and will lose 1% for every 1% that the ETF declines beyond 10%.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Autocallable buffered return enhanced notes
|
| Underlying ETF: | iShares U.S. Medical Devices ETF
|
| Amount: | $1.65 million
|
| Maturity: | March 26, 2026
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If ETF gains, par plus 125% of ETF return; par if ETF declines by no more than 10%; otherwise, 1% loss for every 1% that ETF declines beyond 10%
|
| Call: | Automatically at a premium of 10.62% if the ETF closes at or above its initial value on March 31, 2025
|
| Initial level: | $57.32
|
| Upside leverage: | 125%
|
| Buffer: | 10%
|
| Pricing date: | March 21
|
| Settlement date: | March 26
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 1.75%
|
| Cusip: | 48134WT31
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
